The Cigna Group Declares Quarterly Dividend


Werte in diesem Artikel
Aktien

245.50 EUR -5.30 EUR -2.11 %

BLOOMFIELD, Conn., Oct. 25, 2023 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.23 per share of its common stock, payable on December 21, 2023 to shareholders of record as of the close of business on December 6, 2023.

The Cigna Group (PRNewsfoto/The Cigna Group)

About The Cigna Group

The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Cigna Healthcare, Evernorth Health Services or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 countries and jurisdictions, and has more than 190 million customer relationships around the world. Learn more at thecignagroup.com.

Investor Relations Contact
Ralph Giacobbe
1 (860) 787-7968
Ralph.Giacobbe@cigna.com

Media Contact
Justine Sessions
1 (860) 810-6523
Justine.Sessions@cigna.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/the-cigna-group-declares-quarterly-dividend-301967760.html

SOURCE The Cigna Group

Aktuelle The Cigna Group Registered Aktie News

Werbung

The Cigna Group Registered Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für The Cigna Group Registered nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
20.07.18 Express Scripts Neutral Robert W. Baird & Co. Incorporated
08.03.18 Express Scripts Equal Weight Barclays Capital
08.03.18 Cigna Overweight Barclays Capital
31.01.18 Express Scripts Outperform RBC Capital Markets
15.12.17 Express Scripts Outperform Robert W. Baird & Co. Incorporated